omatic patients, CEA vs carotid artery stenting (CAS) in symptomatic low surgical risk
patients, the optimal timing of revascularization after acute stroke, screening high-risk patients for carotid disease, and
the optimal sequence of interventions in patients with combined coronary and carotid disease. Studies were selected
and appraised by pairs of independent reviewers. Meta-analyses were performed when feasible.
Results: Medical management compared with carotid interventions in asymptomatic patients was